Predictive Value of Mid-luteal Serum Progesterone Levels in Egg Donation Cycles
Launched by INSTITUTO VALENCIANO DE INFERTILIDAD, IVI VALENCIA · Feb 25, 2016
Trial Information
Current as of June 13, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age\<50 yo
- • BMI \< 30Kg/m2
- • Hormonal replacement cycle
- • Endometrial thickness \>6.5 mm during proliferative phase
- • Transfer of one or two blastocyst grade A-B according to ASEBIR
- Exclusion Criteria:
- • Uterine pathology
- • Cryptozoospermia
- • Severe implantation failure (\>6 GQ embryos transferred without success)
About Instituto Valenciano De Infertilidad, Ivi Valencia
Instituto Valenciano de Infertilidad (IVI Valencia) is a leading fertility clinic and research institution dedicated to advancing reproductive health and assisted reproductive technologies. With a commitment to providing personalized care and innovative treatment options, IVI Valencia conducts clinical trials aimed at enhancing the understanding and effectiveness of infertility therapies. The institute combines state-of-the-art facilities with a team of experienced specialists, ensuring high standards of patient safety and ethical research practices. IVI Valencia plays a pivotal role in fostering scientific advancements in the field of reproductive medicine, ultimately striving to improve outcomes for individuals and couples facing fertility challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valencia, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials